#[first_name]
#[create_date]
#[first_name]
#[create_date]
Cilengitide
| Name | Cilengitide |
| Category | Fibronectin Fragments, RGD Peptides |
| One Letter Code | c(RGDf(Me)V) |
| Three Letter Code | Cyclo(-Arg-Gly-Asp-D-Phe-N-Me-Val) |
| Molecular Weight | 588.660 |
| Application | Adhesion Molecules & Extracellular Matrix ProteinsCancer ResearchRegenerative Medicine |
| Cheng, Ngan Ching, Nico van Zandwijk, and Glen Reid. "Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins αvβ3 and αvβ5." PLoS One 9.3 (2014). |
| Mas-Moruno, Carlos, Florian Rechenmacher, and Horst Kessler. "Cilengitide: the first anti-angiogenic small molecule drug candidate. Design, synthesis and clinical evaluation." Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 10.10 (2010): 753-768. |
| Dechantsreiter, Michael A., et al. "N-Methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists." Journal of medicinal chemistry 42.16 (1999): 3033-3040. |